Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
Author(s) -
Harry J. de Koning,
Carlijn M. van der Aalst,
Pim A. de Jong,
Ernst T. Scholten,
Kristiaan Nackaerts,
Marjolein A. Heuvelmans,
JanWillem J. Lammers,
Carla Weenink,
Uraujh Yousaf-Khan,
Nanda Horeweg,
Susan van ’t Westeinde,
Mathias Prokop,
Willem P.Th.M. Mali,
Firdaus A. A. Mohamed Hoesein,
Peter M. A. van Ooijen,
Joachim G.J.V. Aerts,
Michael A. den Bakker,
Erik Thunnissen,
Johny Verschakelen,
Rozemarijn Vliegenthart,
Joan Walter,
Kevin ten Haaf,
Harry J.M. Groen,
Matthijs Oudkerk
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1911793
Subject(s) - lung cancer , computed tomographic , randomized controlled trial , lung cancer screening , medicine , radiology , cancer , clinical trial , computed tomography , nuclear medicine , oncology
There are limited data from randomized trials regarding whether volume-based, low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among male former and current smokers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom